Conserved sequene elements associated with exon skipping

Nucleic Acids Research

Volumn 31, Issue 7, 2003, Pages 1974-1983

  Miriami, Elana ^a,b   Margalit, Hanah ^b   Sperling, Ruth ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; ISOPROTEIN; MESSENGER RNA; PURINE DERIVATIVE; PYRIMIDINE DERIVATIVE;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ALTERNATIVE RNA SPLICING; BASE PAIRING; COMPUTER ANALYSIS; CONTROLLED STUDY; DOWNSTREAM PROCESSING; EXON; GENE CONTROL; GENETIC CONSERVATION; HUMAN; INTRON; ORTHOLOGY; PRIORITY JOURNAL; PROTEIN MOTIF; REVIEW; SEQUENCE ANALYSIS; ANIMAL; ARTICLE; BINDING SITE; GC RICH SEQUENCE; GENETICS; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE;

ALTERNATIVE SPLICING; ANIMALS; BASE SEQUENCE; BINDING SITES; CONSERVED SEQUENCE; DATABASES, NUCLEIC ACID; EXONS; GC RICH SEQUENCE; HUMANS;

EID: 0037394940     PISSN: 03051048     EISSN: None     Source Type: Journal    
DOI: 10.1093/nar/gkg279     Document Type: Review

References (64)

1. Modrek,B. and Lee,C. (2002) A genomic view of alternative splicing. Nature Genet., 30, 13-19.
2. Croft,L., Schandorff,S., Clark,F., Burrage,K., Arctander,P. and Mattick,J.S. (2000) ISIS, the intron information system, reveals the high frequency of alternative splicing in the human genome. Nature Genet., 24, 340-341.
3. Mironov,A.A., Fickett,J.W. and Gelfand,M.S. (1999) Frequent alternative splicing of human genes. Genome Res., 9, 1288-1293.
4. Modrek,B., Resch,A., Grasso,C. and Lee,C. (2001) Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res., 29, 2850-2859.
5. Kan,Z. (2001) Gene structure prediction and alternative splicing analysis using genomically aligned ESTs. Genome Res., 5, 889-900.
6. Breitbart,R.E., Andreadis,A. and Nadal-Ginard,B. (1987) Alternative splicing: a ubiquitous mechanism for generation of multiple protein isoforms from single genes. Annu. Rev. Biochem., 56, 467-495.
7. Grabowski,P.J. and Black,D.L. (2001) Alternative RNA splicing in the nervous system. Progress Neurobiol., 65, 289-308.
8. Clark,F. and Thanaraj,T.A. (2002) Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human. Hum. Mol. Genet., 11, 451-464.
9. Mahotka,C., Wenzel,M., Springer,E., Gabbert,H.E. and Gerharz,C.D. (1999) Survivin-ΔEx3 and Survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties. Cancer Res., 59, 6097-6102.
10. Rodriguez,J.A., Span,S.W., Ferreira,C.G.M., Kruyt,F.A.E. and Giaccone,G. (2002) CRM1-mediated nuclear export determines the cytoplasmic localization of antiapoptotic protein survivin. Exp. Biol. Med., 275, 44-53.
11. Ponnambalam,S., Jackson,A.P., LeBeau,M.M., Pravtcheva,D., Ruddle,F.H., Alibert,C. and Parham,P. (1994) Chromosomal location and some structural features of human clathrin light-chain genes (CLTA and CLTB). Genomics, 24, 440-444.
12. Duncan,P.I., Stojdl,D.F., Marius,R.M., Scheit,K.H. and Bell,J.C. (1998) The Clk2 and Clk3 dual-specificity protein kinases regulate the intranuclear distribution of SR proteins and influence pre-mRNA splicing. Exp. Cell Res., 241, 300-308.
13. Cooper,T.A. and Mattox,W. (1997) The regulation of splice site selection and its role in human disease. Am. J. Hum. Genet., 61, 259-266.
14. Sakamoto,J., Takata,A., Fukuzawa,R., Kikuchi,H., Sugiyama,M., Kanamori,Y., Hashizume,K. and Hata,J.I. (2001) A novel WT1 gene mutation associated with wilms' tumor and congenital male genitourinary malformation. Pediatr. Res., 50, 337-344.
15. Liu,H.-X., Cartegni,L., Zhang,M.Q. and Krainer,A.R. (2001) A mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nature Genet., 27, 55-58.
16. Cartegni,L., Chew,S.L. and Krainer,A.R. (2002) Listening to silence and understanding nonsense: exonic mutations that effect splicing. Nature Rev. Genet., 3, 285-298.
17. Fu,X.D. (1995) The superfamily of arginine/serine-rich splicing factors. RNA, 1, 663-680.
18. Liu,H.-X., Chew,S.L., Cartegni,L., Zhang,M.Q. and Krainer,A.R. (2000) Exonic splicing enhancer motif recognized by human SC35 under splicing conditions. Mol. Cell. Biol., 20, 1063-1071.
19. Dreyfuss,G., Matunis,M.J., Pinol-Roma,S. and Burd,C.G. (1993) hnRNP proteins and the biogenesis of mRNA. Annu. Rev. Biochem., 62, 289-321.
20. McCarthy,E.M.S. and Phillips,J.A.,III (1998) Characterization of an intron splice enhancer that regulates alternative splicing of human GH pre-mRNA. Hum. Mol. Genet., 7, 1491-1496.
21. Coward,E., Haas,S.A. and Vingron,M. (2002) SpliceNest: visualizing gene structure and alternative splicing based on EST clusters. Trends Genet., 18, 53-55.
22. Burge,C.B., Tuschl,T. and Sharp,P.A. (1999) Splicing of precursors to mRNAs by the spliceosomes. In Gesteland,R.F., Cech,T.R. and Atkins,J.F. (eds), The RNA World, 2nd Edn. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, pp. 525-560.
23. Wollerton,M.C., Gooding,C., Robinson,F., Brown,E.C., Jackson,R.J. and Smith,C.W.J. (2001) Differential alternative splicing activity of isoforms of polypyrimidine tract binding protein (PTB). RNA, 7, 819-832.
24. Wagner,E.J. and Garcia-Blanco,M.A. (2001) Polypyrimidine tract binding protein antagonizes exon definition. Mol. Cell. Biol., 21, 3281-3288.
25. Bailey,T.L. and Elkan,C. (1994) Fitting a Mixture Model by Expectation Maximization to Discover Motifs in Biopolymers. International Conference on Intelligent Systems for Molecular Biology. AAAI Press, Menlo Park, CA, pp. 28-36.
26. Lawrence,C.E., Altschul,S.F., Boguski,M.S., Liu,J.S., Neuwald,A.F. and Wootton,J.C. (1993) Detecting subtle sequence signals: Gibbs sampling strategy for multiple alignment. Science, 262, 208-214.
27. Lim,L.P. and Burge,C.B. (2001) A computational analysis of sequence features involved in recognition of short introns. Proc. Natl Acad. Sci. USA, 98, 11193-11198.
28. Shapiro,M.B. and Senapathy,P. (1987) RNA splice junctions of different classes of eukaryotes: sequences statistics and functional implications in gene expression. Nucleic Acids Res., 15, 7155-7174.
29. Cote,J., Dupuis,S. and Wu,J.Y. (2001) Polypyrimidine track-binding protein binding downstream of caspase-2 alternative exon 9 represses its inclusion. J. Biol. Chem., 276, 8535-8543.
30. Chou,M.Y., Underwood,J.G., Nikollc,J., Luu,M.H. and Black,D.L. (2000) Multisite RNA binding and release of Polypyrimidine tract binding protein during the regulation of c-src neural-specific splicing. Mol. Cell., 5, 949-57.
31. Deguillien,M., Huang,S.-C., Morinière,M., Dreumont,N., Benz,E.J.,Jr and Baklouti,F. (2001) Multiple cis elements regulate an alternative splicing event at 4.1 R pre-mRNA during erythroid differentiation. Blood, 98, 3809-3816.
32. Nussinov,R. (1988) Conserved quartets near 5′ intron junctions in primate nuclear pre-mRNA. J. Theor. Biol., 133, 73-84.
33. Carlo,T., Sierra,R. and Berget,S.M. (2000) A 5′ splice sites-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol. Cell. Biol., 20, 3988-3995.
34. Hastings,M.L., Wilson,C.M. and Munroe,S.H. (2001) A purine-rich intronic elements enhance alternative splicing of the thyroid hormone receptor mRNA. RNA, 7, 859-874.
35. McCullough,A.J. and Berget,S.M. (2000) An intronic splicing enhancer binds U1 snRNPs to enhance splicing and select 5′ splice sites. Mol. Cell. Biol., 20, 9225-9235.
36. Sirand-Pugnet,P., Durosay,P., Brody,E. and Marie,J. (1995) An intronic (A/G)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res., 23, 3501-3507.
37. Mendell,J. and Dietz,H.C. (2001) When the massage goes awry: disease-producing mutations that influence mRNA content and performance. Cell, 107, 411-414.
38. Blanchette,M. and Chabot,B. (1999) Modulation of exon skipping by high-affinity hnRNP A1-binding sites and by intron elements that repress splice site utilization. EMBO J., 18, 1939-1952.
39. Zhang,L., Liu,W. and Grabowski,P.J. (1999) Coordinate repression of trio of neuron-specific splicing events by the splicing regulator PTB. RNA, 5, 117-130.
40. Expert-Bezançon,A., Le Caer,J.P. and Marie,J. (2002) Heterogeneous nuclear ribonucleoprotein (hnRNP) K Is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken β-tropomyosin pre-mRNA. J. Biol. Chem., 277, 16614-16623.
41. Makeyev,A. and Liebhaber,S.A. (2002) The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA, 8, 265-278.
42. Shnyreva,M., Schullery,D.S., Suzuki,H., Higaki,Y. and Bomsztyk,K. (2000) Interaction of two multifunctional proteins heterogeneous nuclear ribonucleoprotein K and Y-box-binding protein. J. Biol. Chem., 275, 15498-15503.
43. Brudno,M., Gelfand,M.S., Spengler,S., Zorn,M., Dubchak,I. and Conboy,J.G. (2001) Computational analysis of candidate intron regulatory elements for tissue-specific alternative pre-mRNA splicing. Nucleic Acids Res., 29, 2338-2348.
44. Chan,R.C. and Black,D.L. (1997) The polypyrimidine tract binding protein binds upstream of neural cell-specific c-src exon N1 to repress the splicing of the intron downstream. Mol. Cell. Biol., 17, 4667-4676.
45. Guo,N. and Kawamoto,S. (2000) An intronic downstream enhancer promotes 3′ splice site usage of neural cell-specific exon. J. Biol. Chem., 275, 33641-33649.
46. Lim,L.P. and Sharp,P.A. (1998) Alternative splicing of the fibronectin EIIIB exon depends on specific TGCATG repeats. Mol. Cell. Biol., 18, 3900-3906.
47. Estes,P.A., Cooke,N.E. and Liebhaber,S.A. (1992) A native RNA secondary structure controls alternative splice-site selection and generates two human growth hormone isoforms. J. Biol. Chem., 267, 14902-14908.
48. Libri,D., Piseri,A. and Fiszman,M.Y. (1991) Tissue-specific splicing in vivo of beta-tropomyosin gene: dependence on an RNA secondary structure. Science, 252, 1842-1845.
49. Clouetd'Orval,B., d'Aubenton-Carafa,Y., Brody,J.M. and Brody,E. (1991) Determination of an RNA structure involved in splicing inhibition of a muscle-specific exon. J. Mol. Biol., 221, 837-856.
50. Varani,L., Hasegawa,M., Spillantini,M.G., Smith,M.J., Murrell,J.R., Ghetti,B., Klug,A., Goedert,M. and Varani,G. (1999) Structure of tau exon 10 splicing regulatory element RNA and destabilization by mutations of frontotemporal dementia and parkinsonism linked to chromosome 17. Proc. Natl Acad. Sci. USA, 96, 8229-8234.
51. Blanchette,M. and Chabot,B. (1997) A highly stable duplex structure sequesters the 5′ splice site region of hnRNP A1 alternative exon 7B. RNA, 3, 405-419.
52. Coleman,T.P. and Roesser,J.R. (1998) RNA secondary structure: an important cis-element in rat calcitonin/CGRP pre-messenger RNA splicing. Biochemistry, 37, 15941-15950.
53. DelGatto,F., Plet,A., Gesnel,M.-C., Fort,C. and Breathnach,R. (1997) Multiple interdependent sequence elements control splicing of a Fibroblast growth factor receptor 2 alternative exon. Mol. Cell. Biol., 17, 5106-5116.
54. Howe,K.J. and Ares,M.Jr (1997) Intron self-complementarity enforces exon inclusion in a yeast pre-mRNA. Proc. Natl Acad. Sci. USA, 94, 12467-12472.
55. Gooding,C., Roberts,G.C. and Smith,C.W.J. (1998) Role of an inhibitory pyrimidine element and general pyrimidine tract binding protein in repression of a regulated alpha-tropomyosin exon. RNA, 4, 85-100.
56. LeGuiner,C., Plet,A., Gallana,D., Gesnel,M.C., Del Gatto-Konczak,F. and Breathnach,R. (2001) Polypyrimidine tract-binding protein represses splicing of a fibroblast growth factor receptor-2 gene alternative exon through exon sequences. J. Biol. Chem., 276, 43677-43687.
57. Carstens,R.P., Wagner,E.P. and Garcia-Blanco,M.A. (2000) An intronic splicing silencer causes skipping of IIIb exon of fibroblast growth factor receptor 2 through involvement of polypyrimidine tract binding protein. Mol. Cell. Biol., 20, 7388-7400.
58. Jin,W., Huang,E.S.-C., Bi,W. and Cote,G.J. (1999) Redundant intronic repressors function to inhibit fibroblast growth factor receptor-1α-exon recognition in glioblastoma cells. J. Biol. Chem., 274, 28035-28041.
59. Jin,W., McCutcheon,I.E., Fuller,G.N., Huang,E.S. and Cote,G.J. (2000) Fibroblast growth factor receptor-I α-exon exclusion and polypyrimidine tract-binding protein in glioblastoma multiforme tumors. Cancer Res., 60, 1221-1224.
60. Lou,H., Yang,Y., Cote,G.J., Berget,S.M. and Gagel,R.F. (1995) An intron enhancer containing a 5′ splice site sequence in the human calcitonin/calcitonin gene-related peptide gene. Mol. Cell. Biol., 15, 7135-7142.
61. Lou,H., Helfman,D.M., Gagel,R.F. and Berget,S.M. (1999) Polypyrimidine tract-binding protein positively regulates inclusion of alternative 3′-terminal exon. Mol. Cell. Biol., 19, 78-85.
62. Ashiya,M. and Grabowski,P.J. (1997) A neuron-specific splicing switch mediated by an array of pre-mRNA repressor sites: evidence of regulatory role for the polypyrimidine tract binding protein and a brain-specific PTB counterpart. RNA, 3, 996-1015.
63. Markovtsov,V., Nikollc,J.M., Goldman,J.A., Turck,C.W., Chou,M.Y. and Black,D.L. (2000) Cooperative assembly of an hnRNP complex induced by a tissue-specific homolog of polypyrimidine tract binding protein. Genes Dev., 10, 208-219.
64. Southby,J., Gooding,C. and Smith,C.W. (1999) Polypyrimidine tract binding protein functions as a repressor to regulate alternative splicing of α-actinin mutally exclusive exons. Mol. Cell. Biol., 19, 2699-2711.